These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 22344673)

  • 1. Utility of positron-emission tomography/computed tomography imaging in the management of the neck in recurrent laryngeal cancer.
    Gilbert MR; Branstetter BF; Kim S
    Laryngoscope; 2012 Apr; 122(4):821-5. PubMed ID: 22344673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Occult nodal disease in patients with failed laryngeal preservation undergoing surgical salvage.
    Koss SL; Russell MD; Leem TH; Schiff BA; Smith RV
    Laryngoscope; 2014 Feb; 124(2):421-8. PubMed ID: 24323309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neck management in patients undergoing postradiotherapy salvage laryngeal surgery for recurrent/persistent laryngeal cancer.
    Farrag TY; Lin FR; Cummings CW; Koch WM; Flint PW; Califano JA; Broussard J; Bajaj G; Tufano RP
    Laryngoscope; 2006 Oct; 116(10):1864-6. PubMed ID: 17003711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positron emission tomography-CT prediction of occult nodal metastasis in recurrent laryngeal cancer.
    Rosko A; Birkeland A; Shuman A; Prince M; Bradford C; Wolf G; Worden F; Eisbruch A; Srinivasan A; Wong KK; Spector ME
    Head Neck; 2017 May; 39(5):980-987. PubMed ID: 28236331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is elective neck dissection necessary in cases of laryngeal recurrence after previous radiotherapy for early glottic cancer?
    Deganello A; Meccariello G; Bini B; Paiar F; Santoro R; Mannelli G; Gallo O
    J Laryngol Otol; 2014 Dec; 128(12):1089-94. PubMed ID: 25418930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positron emission tomography/computerized tomography (PET/CT) scanning for preoperative staging of patients with oral/head and neck cancer.
    Nahmias C; Carlson ER; Duncan LD; Blodgett TM; Kennedy J; Long MJ; Carr C; Hubner KF; Townsend DW
    J Oral Maxillofac Surg; 2007 Dec; 65(12):2524-35. PubMed ID: 18022480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deferring planned neck dissection following chemoradiation for stage IV head and neck cancer: the utility of PET-CT.
    Nayak JV; Walvekar RR; Andrade RS; Daamen N; Lai SY; Argiris A; Smith RP; Heron DE; Ferris RL; Johnson JT; Branstetter BF
    Laryngoscope; 2007 Dec; 117(12):2129-34. PubMed ID: 17921898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of the N0 neck in recurrent laryngeal squamous cell carcinoma.
    Bohannon IA; Desmond RA; Clemons L; Magnuson JS; Carroll WR; Rosenthal EL
    Laryngoscope; 2010 Jan; 120(1):58-61. PubMed ID: 19877259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Occult Nodal Disease Prevalence and Distribution in Recurrent Laryngeal Cancer Requiring Salvage Laryngectomy.
    Birkeland AC; Rosko AJ; Issa MR; Shuman AG; Prince ME; Wolf GT; Bradford CR; McHugh JB; Brenner JC; Spector ME
    Otolaryngol Head Neck Surg; 2016 Mar; 154(3):473-9. PubMed ID: 26884365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrent head and neck cancer: United Kingdom National Multidisciplinary Guidelines.
    Mehanna H; Kong A; Ahmed SK
    J Laryngol Otol; 2016 May; 130(S2):S181-S190. PubMed ID: 27841130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Revisiting the role of positron-emission tomography/computed tomography in determining the need for planned neck dissection following chemoradiation for advanced head and neck cancer.
    Gourin CG; Boyce BJ; Williams HT; Herdman AV; Bilodeau PA; Coleman TA
    Laryngoscope; 2009 Nov; 119(11):2150-5. PubMed ID: 19544378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elective neck dissection for no neck during salvage total laryngectomy: findings, complications, and oncological outcome.
    Basheeth N; O'Leary G; Sheahan P
    JAMA Otolaryngol Head Neck Surg; 2013 Aug; 139(8):790-6. PubMed ID: 23949354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 18F-FDG PET/CT for detecting nodal metastases in patients with oral cancer staged N0 by clinical examination and CT/MRI.
    Schöder H; Carlson DL; Kraus DH; Stambuk HE; Gönen M; Erdi YE; Yeung HW; Huvos AG; Shah JP; Larson SM; Wong RJ
    J Nucl Med; 2006 May; 47(5):755-62. PubMed ID: 16644744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Positron emission tomography in the evaluation of the negative neck in patients with oral cavity cancer.
    Myers LL; Wax MK
    J Otolaryngol; 1998 Dec; 27(6):342-7. PubMed ID: 9857320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of FDG PET in management of neck metastasis from head-and-neck cancer after definitive radiation treatment.
    Yao M; Smith RB; Graham MM; Hoffman HT; Tan H; Funk GF; Graham SM; Chang K; Dornfeld KJ; Menda Y; Buatti JM
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):991-9. PubMed ID: 16099601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N2 disease in patients with head and neck squamous cell cancer treated with chemoradiotherapy: is there a role for posttreatment neck dissection?
    Cho AH; Shah S; Ampil F; Bhartur S; Nathan CO
    Arch Otolaryngol Head Neck Surg; 2009 Nov; 135(11):1112-8. PubMed ID: 19917924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for distant metastases before salvage surgery in patients with recurrent head and neck squamous cell carcinoma: a retrospective case series comparing thoraco-abdominal CT, positron emission tomography and abdominal ultrasound.
    Fakhry N; Michel J; Colavolpe C; Varoquaux A; Dessi P; Giovanni A
    Clin Otolaryngol; 2012 Jun; 37(3):197-206. PubMed ID: 22520870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of [18F]-2-fluorodeoxyglucose-positron emission tomography/computed tomography on previously untreated head and neck cancer patients.
    Fleming AJ; Smith SP; Paul CM; Hall NC; Daly BT; Agrawal A; Schuller DE
    Laryngoscope; 2007 Jul; 117(7):1173-9. PubMed ID: 17603315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Level IIb lymph node metastasis in laryngeal squamous cell carcinoma.
    Lim YC; Lee JS; Koo BS; Choi EC
    Laryngoscope; 2006 Feb; 116(2):268-72. PubMed ID: 16467717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ability of positron emission tomography to detect residual neck node disease in patients with head and neck squamous cell carcinoma after definitive chemoradiotherapy.
    Tan A; Adelstein DJ; Rybicki LA; Saxton JP; Esclamado RM; Wood BG; Lorenz RR; Strome M; Carroll MA
    Arch Otolaryngol Head Neck Surg; 2007 May; 133(5):435-40. PubMed ID: 17515501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.